Showing 841 - 860 results of 10,572 for search '"tumors"', query time: 0.10s Refine Results
  1. 841

    Two Cases of Sarcoma Arising in Giant Cell Tumor of Bone Treated with Denosumab by Cory Julian Broehm, Erika L. Garbrecht, Jeff Wood, Therese Bocklage

    Published 2015-01-01
    “…Giant cell tumor (GCT) of bone is a generally benign, but often locally aggressive, neoplasm of bone, with a propensity for recurrence. …”
    Get full text
    Article
  2. 842

    TREM2 promotes the formation of a tumor-supportive microenvironment in hepatocellular carcinoma by Hanrui Guo, Meiling Wang, Caiya Ni, Chun Yang, Chunxue Fu, Xiaoman Zhang, Xueling Chen, Xiangwei Wu, Jun Hou, Lianghai Wang

    Published 2025-01-01
    “…This study aimed to evaluate the role of TREM2 in the tumor microenvironment in the context of HCC progression. …”
    Get full text
    Article
  3. 843

    The Clinical Impact of Tumor Grade Heterogeneity in Nonmuscle- invasive Urothelial Carcinoma of the Bladder by Meftun Culpan, Ferhat Keser, Ayberk İplikci, Gözde Kır, Gökhan Atış, Asif Yıldırım

    Published 2021-12-01
    “…Objective: This study aimed to determine the oncological outcomes of mixed-grade tumors by comparing them with pure low-grade and high-grade tumors. …”
    Get full text
    Article
  4. 844

    MRI Findings of Causalgia of the Lower Extremity Following Transsphenoidal Resection of Pituitary Tumor by D. Ryan Ormond, Augustine L. Moscatello, Raj Murali

    Published 2012-01-01
    “…Here we report a case of lower extremity causalgia following elective transsphenoidal resection of a pituitary tumor in a young man. Clinical Presentation. A 33-year-old man with acromegaly underwent elective sublabial transsphenoidal resection of his pituitary tumor. …”
    Get full text
    Article
  5. 845
  6. 846

    Four-Rod Stabilization of Severely Destabilized Lumbar Spine Caused by Metastatic Tumor by Isao Shibuya, Koichi Sairyo, Yasuo Kanamori, Akira Dezawa

    Published 2013-01-01
    “…We report a case of a 67-year-old female with severely destabilized lumbar spine caused by metastatic malignant tumor. The primary lesion was a thyroid follicular adenocarcinoma. …”
    Get full text
    Article
  7. 847

    USP4-mediated CENPF deubiquitylation regulated tumor metastasis in colorectal cancer by Zhongdong Xie, Hanbin Lin, Yuecheng Wu, Yanan Yu, Xintong Liu, Yating Zheng, Xiaojie Wang, Jiashu Wu, Meifang Xu, Yuting Han, Qiongying Zhang, Yu Deng, Lin Lin, Yan Linzhu, Li Qingyun, Xinjian Lin, Ying Huang, Pan Chi

    Published 2025-02-01
    “…We found that CENPF expression was preferentially elevated in CRC tissues compared to adjacent normal tissues, with significantly higher levels in CRC patients with tumor recurrence. Furthermore, a multicenter cohort study demonstrated that upregulated CENPF expression was strongly associated with poorer disease-free survival in CRC. …”
    Get full text
    Article
  8. 848

    Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy by Shuyan He, Lu Zheng, Chunjian Qi

    Published 2025-01-01
    “…This review describes the origins and phenotypes of MDSCs, their biological roles in tumor progression, and regulatory mechanisms, with a focus on current therapeutic approaches targeting tumor-associated MDSCs. …”
    Get full text
    Article
  9. 849

    Mucinous Carcinomatosis: A Rare Association between an Ovarian Tumor and an E-GIST by Hugo Palma Rios, André Goulart, Pedro Leão

    Published 2018-01-01
    “…Pseudomyxoma peritonei (PMP) and extragastrointestinal stromal tumors (E-GISTs) are both rare entities. Most of the time, PMP is associated with an appendiceal tumor. …”
    Get full text
    Article
  10. 850
  11. 851

    Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better by Ming Zheng

    Published 2022-01-01
    “…Background Recently, the US Food and Drug Administration (FDA) has approved immune checkpoint blockade (ICB) for treating cancer patients with tumor mutation burden (TMB) >10 mutations/megabase (mut/Mb). …”
    Get full text
    Article
  12. 852
  13. 853
  14. 854

    Tumor organoids in cancer medicine: from model systems to natural compound screening by Rong Cong, Can Lu, Xinying Li, Zhijie Xu, Yaqin Wang, Shusen Sun

    Published 2025-12-01
    “…Context The advent of tissue engineering and biomedical techniques has significantly advanced the development of three-dimensional (3D) cell culture systems, particularly tumor organoids. These self-assembled 3D cell clusters closely replicate the histopathological, genetic, and phenotypic characteristics of primary tissues, making them invaluable tools in cancer research and drug screening.Objective This review addresses the challenges in developing in vitro models that accurately reflect tumor heterogeneity and explores the application of tumor organoids in cancer research, with a specific focus on the screening of natural products for antitumor therapies.Methods This review synthesizes information from major databases, including Chemical Abstracts, Medicinal and Aromatic Plants Abstracts, ScienceDirect, Google Scholar, Scopus, PubMed and Springer Link. …”
    Get full text
    Article
  15. 855

    Comparison of Myeloid Cells in Circulation and in the Tumor Microenvironment of Patients with Colorectal and Breast Cancers by Salman M. Toor, Eyad Elkord

    Published 2017-01-01
    “…We have previously reported levels of myeloid cells in the periphery and in the tumor microenvironment (TME) of patients with primary breast cancer (PBC) and colorectal cancer (CRC). …”
    Get full text
    Article
  16. 856
  17. 857
  18. 858

    Stimulus-activated ribonuclease targeting chimeras for tumor microenvironment activated cancer therapy by Yuqi Zhang, Jinfeng Zhu, Ling Qiu, Zhengzhong Lv, Zhongsheng Zhao, Xingxiang Ren, Yirui Guo, Yan Chen, Miao Li, Yurong Fan, Zhixin Han, Yiming Feng, Haibin Shi

    Published 2025-02-01
    “…Here, a RiboTAC is designed for tumor microenvironment triggered activation. The tumor microenvironment activated RiboTAC (TaRiboTAC) incorporates two pre-miR-21 binders, a near-infrared fluorophore IR780, an RGD targeting peptide and a phenylboronic acid caged ribonuclease recruiter. …”
    Get full text
    Article
  19. 859

    The Tumor Necrosis Factor Superfamily of Cytokines in the Inflammatory Myopathies: Potential Targets for Therapy by Boel De Paepe, Kim K. Creus, Jan L. De Bleecker

    Published 2012-01-01
    “…The crucial role played by tumor necrosis factor alpha (TNFα) in the IM has long been recognized. …”
    Get full text
    Article
  20. 860